Citation Impact
Citing Papers
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
1991 Standout
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.
1998
Altered metabolism of thrombospondin by Chinese hamster ovary cells defective in glycosaminoglycan synthesis.
1988
The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation.
1995
A rapid quantitative assay for the detection of mammalian heparanase activity
1997
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Heparin-Protein Interactions
2002 Standout
Structure and Biological Activity of Heparin
1985
Pathological considerations in replacement cardiac valves
1992
Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement
2000
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
1995 StandoutNobel
Minimal Sulfated Carbohydrates for Recognition by L-selectin and the MECA-79 Antibody
2000 StandoutNobel
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Human Fibrinogen
1988
Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.
1998
Chemokines — Chemotactic Cytokines That Mediate Inflammation
1998 Standout
Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis
1992
Vitamin E Consumption and the Risk of Coronary Heart Disease in Men
1993 Standout
Human platelet factor 4 monomer-dimer-tetramer equilibria investigated by proton NMR spectroscopy
1989
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
Renal handling of albumin: A critical review of basic concepts and perspective
2002
Thrombospondin as a regulator of angiogenesis
1997
Uric Acid and Cardiovascular Risk
2008 Standout
Specific Binding of the Chemokine Platelet Factor 4 to Heparan Sulfate
1997
Heat Stroke
2002 Standout
Angiogenesis in cancer and other diseases
2000 StandoutNature
The human basophil
1990
Smoking, hemorheologic factors, and progression of peripheral arterial disease in patients with claudication
1998
Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men
1995 Standout
Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells
1998
Platelet Activation and Atherothrombosis
2007 Standout
Serum Uric Acid and Coronary Heart Disease in 9,458 Incident Cases and 155,084 Controls: Prospective Study and Meta-Analysis
2005
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes
1993
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
The influence of smoking cessation and hypertriglyceridaemia on the progression of peripheral arterial disease and the onset of critical ischaemia
1996
Initial sequence of the chimpanzee genome and comparison with the human genome
2005 StandoutNature
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
2004 Standout
Nonlinear elasticity in biological gels
2005 StandoutNature
The pathogenic basis of malaria
2002 StandoutNature
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Heparin and Low-Molecular-Weight Heparin
1998
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer
2010
Atherosclerosis — An Inflammatory Disease
1999 Standout
Complement
2001 Standout
Alcohol Consumption and Risk of Peripheral Arterial Disease : The Rotterdam Study
2002
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
The return of glomerular-filtered albumin to the rat renal vein
1999
Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters
2003
Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin
1990
Humanized Antibodies as Potential Therapeutic Drugs
1998
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
1997 Standout
Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene
1991
Angiogenesis as a therapeutic target
2005 StandoutNature
Randomized Trial of Low Molecular Weight Heparin (Dalteparin) in Prevention of Left Ventricular Thrombus Formation and Arterial Embolism After Acute Anterior Myocardial Infarction: The Fragmin in Acute Myocardial Infarction (FRAMI) Study 11This study was supported by grants from the Norwegian Council on Cardiovascular Diseases, Oslo, Norway and Pharmacia AB, Stockholm, Sweden.
1997
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Human Platelet Factor 4 and Its C-Terminal Peptides: Heparin Binding and Clearance from the Circulation
1990
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Local imbalance of proangiogenic and antiangiogenic factors: a potential mechanism of focal necrosis and dormancy in tumors.
2000
Determinants of peripheral arterial disease in the elderly: the Rotterdam study.
2000
A Histomorphometric Evaluation of Heparin-Induced Bone Loss After Discontinuation of Heparin Treatment in Rats
1999
Reversal of Heparin Anticoagulation by Recombinant Platelet Factor 4 in Humans
1995
Platelet-derived growth factor in vivo: levels, activity, and rate of clearance
1984
Demonstration of an antibody against platelet-derived growth factor
1981
C-Reactive Protein, Fibrin D-Dimer, and Incident Ischemic Heart Disease in the Speedwell Study
2001
Lymphocyte Homing and Homeostasis
1996 StandoutScience
CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells
1997
Purification and structural studies of a major scrapie prion protein
1984 StandoutNobel
Plasminogen Activators, Tissue Degradation, and Cancer
1985 Standout
Inhibition of Endothelial Regeneration by Type-Beta Transforming Growth Factor from Platelets
1986 StandoutScience
Recent advances in molecular pathology
1984
Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
1994
Anticoagulation Monitoring during Cardiac Surgery
1999
Kinetics of intravenously administered heparin in normal humans
1982
Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing
1999
The Epidemiology of Peripheral Arterial Disease: Importance of Identifying the Population at Risk
1997
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Bacteriophage T4 mutants deficient in alteration and modification of the Escherichia coli RNA polymerase
1974 StandoutNobel
Prospective Study of Moderate Alcohol Consumption and Risk of Peripheral Arterial Disease in US Male Physicians
1997
von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects
1999
A Chondroitin Sulfate Proteoglycan on Human Neutrophils Specifically Binds Platelet Factor 4 and Is Involved in Cell Activation
1998
Low molecular weight heparin
1992
An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration.
1994
Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4.
1986
Self-Assembled Organic Monolayers: Model Systems for Studying Adsorption of Proteins at Aurfaces
1991 StandoutScience
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
1990 StandoutNobel
Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase.
1982
Epidemiology of Peripheral Artery Disease
2015 Standout
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
1988 StandoutScience
Cell biology of arterial proteoglycans.
1989
Why the kidney glomerulus does not clog: A gel permeation/diffusion hypothesis of renal function
2003 StandoutNobel
Advances in platinum metal carbonyls and their substituted derivatives. II. Rhodium, iridium, palladium and platinum carbonyls
1976
The distal half of the tail fibre of bacteriophage T4
1979
Renal Insufficiency and the Risk of Lower Extremity Peripheral Arterial Disease
2004
The Role of Eicosanoids in Reproduction
1999
Coronary Plaque Erosion Without Rupture Into a Lipid Core
1996
Coronary Plaque Disruption
1995 Standout
Prevention of Postoperative Venous Thrombosis: A Randomized Trial Comparing Unfractionated Heparin with Low Molecular Weight Heparin in Patients Undergoing Total Hip Replacement
1988
Proteolytic cleavage of the precursor of von Willebrand factor is not essential for multimer formation.
1988
Third-Generation Biomedical Materials
2002 StandoutScience
Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.
1994
Structural determinants of glomerular permeability
2001
Peripheral Arterial Disease in the Elderly
1998
Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men.
1994
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
Prohormone processing in Xenopus oocytes: characterization of cleavage signals and cleavage enzymes.
1991 StandoutNobel
Albumin modulates lateral assembly of fibrin polymers: evidence of enhanced fine fibril formation and of unique synergism with fibrinogen
1987
Tumors: Wounds That Do Not Heal
1986 Standout
Disappearance of circulating anti-Xa activity after intravenous injection of standard heparin and of a low molecular weight heparin (CY 216) in normal and nephrectomized rabbits
1985
The biology of platelet-derived growth factor
1986 Standout
Fibrinogen and Silent Atherosclerosis in Subjects With Cardiovascular Risk Factors
1995
The Pathogenesis of Atherosclerosis — An Update
1986 Standout
Plasma P-selectin is increased in thrombotic consumptive platelet disorders
1994
Low molecular weight heparin
1992
Adsorption of CO on Pd(100)
1980 StandoutNobel
Works of J. Dawes being referenced
Safety and pharmacokinetics of the low molecular weight heparinoid Org 10172 administered to healthy elderly volunteers.
1989
Release of Highly-Sulphated Glycosaminoglycans and Histamine from Human Basophils
1988
Interactions of Heparins in the Vascular Environment
1993
Thrombospondin in malignant and non-malignant breast tissue
1989
Neutrophil activation in pregnancy‐induced hypertension
1989
Measurement of the affinities of heparins, naturally occurring glycosaminoglycans, and other sulfated polymers for antithrombin III and thrombin
1988
Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease
1993
The effects of hyperthermia on human endothelial monolayers
1994
Absorption of heparin, LMW heparin and SP54 after subcutaneous injection, assessed by competitive binding assay
1986
Mercuric halide adducts of dicarbonylcyclopentadienylrhodium and cyclo-octa-1,5-dienecyclopentadienyliridium
1968
A Comparative Study Using Immunological and Biological Assays of the Haemostatic Responses to DDAVP Infusion Venous Occlusion and Exercise in Normal Men
1984
Detection of Enhanced In Vivo Platelet α-Granule Release in Different Patient Groups - Comparison of β-Thromboglobulin, Platelet Factor 4 and Thrombospondin Assays
1984
A radioimmunoassay for thrombospondin, used in a comparative study of thrombospondin, β-thromboglobulin and platelet factor 4 in healthy volunteers
1983
The in vivo release of human platelet factor 4 by heparin
1982
Monoclonal Antibodies, Their Production and Potential in Clinical Practice
1984
Binding of platelet factor 4 to cultured human umbilical vein endothelial cells
1980
Functions of baseplate components in bacteriophage T4 infection: I. Dihydrofolate reductase and dihydropteroylhexaglutamate
1973
Elevation of plasma β-thromboglobulin in patients with prosthetic cardiac valves
1981
Characterisation of the bacteriophage T4 receptor site
1975 Nature
Tandem purification of mouse IgM monoclonal atibodies produced in vitro using anion-exchange and gel fast protein liquid chromatography
1986
Comparison of secretion and subcellular localization of von Willebrand protein with that of thrombospondin and fibronectin in cultured human vascular endothelial cells
1985
Comparative evaluation of plasma thrombospondin β-thromboglobulin and platelet factor 4 in acute myocardial infarction
1985
Relationship between Biological Activity and Concentration of a Low-Molecular-Weight Heparin (PK 10169) and Unfractionated Heparin after Intravenous and Subcutaneous Administration
1986
Nasal Histamine and Heparin in Chronic Rhinitis
1988
Role of the Liver and Kidney in the Desulphation of Heparin in vivo
1995
Monoclonal antibodies directed against human α-thrombin and the thrombin-antithrombin III complex
1984
Plasma thrombospondin in patients with chronic renal failure, liver disease and splenectomy
1985
Human Vascular Endothelial Cells Catabolise Exogenous Glycosaminoglycans by a Novel Route
1992
Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study.
1993
Catabolism of low-dose heparin in man
1979
Desulphation of dextran sulphate during kidney ultrafiltration
1994
Inflammatory response, neutrophil activation, and free radical production after acute myocardial infarction: effect of thrombolytic treatment.
1990
The release, distribution, and clearance of human β-thromboglobulin and platelet factor 4
1978